Immunovant (IMVT) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.76
-0.71
-0.65
-0.6

Details

Expected EPS
-0.680351
Actual EPS
-0.71
Surprise EPS
-0.03
Surprise Percent
+4.36%

Description

Immunovant (IMVT) has reported earnings of -0.71 per share for Q3 2025.

0 Comments

Share your thoughts